Selected biomarkers of depression: what are the effects of cytokines and inflammation
Open accessThe DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index; 27 of the 178 sources its claims cite were checked for support.
Abstract
Depression is one of the leading mental illnesses worldwide and lowers the quality of life of many. According to WHO, about 5% of the worldwide population suffers from depression. Newer studies report a staggering global prevalence of 27.6%, and it is rising. Professionally, depression belonging to affective disorders is a psychiatric illness, and the category of major depressive disorder (MDD) comprises various diagnoses related to persistent and disruptive mood disorders. Due to this fact, it is imperative to find a way to assess depression quantitatively using a specific biomarker or a panel of biomarkers that would be able to reflect the patients’ state and the effects of therapy. Cytokines, hormones, oxidative stress markers, and neuropeptides are studied in association with depression. The latest research into inflammatory cytokines shows that their relationship with the etiology of depression is causative. There are stronger cytokine reactions to pathogens and stressors in depression. If combined with other predisposing factors, responses lead to prolonged inflammatory processes, prolonged dysregulation of various axes, stress, pain, mood changes, anxiety, and depression. This review focuses on the most recent data on cytokines as markers of depression concerning their roles in its pathogenesis, their possible use in diagnosis and management, their different levels in bodily fluids, and their similarities in animal studies. However, cytokines are not isolated from the pathophysiologic mechanisms of depression or other psychiatric disorders. Their effects are only a part of the whole pathway.
Overview
CoChat Summary
TL;DR
This narrative review summarizes evidence that inflammatory cytokines such as IL-1β, IL-6, IL-12, IL-18, IFN-γ, and TNF are altered in depression and may serve as biomarkers for diagnosis, severity, and treatment response. It concludes that cytokines are viable research targets, but findings are inconsistent and causality remains unclear.
Key findings
- Cytokines including IL-1β, IL-6, IL-12, IL-18, IFN-γ, and TNF-α are repeatedly associated with depression; the review concludes they are viable options for quantitative depression research, preferably using non-invasively collected bodily fluids.
- Meta-analytic evidence cited includes elevated IL-3 in depression (107 studies, 5,166 patients and 5,083 controls), elevated IL-12 in an 82-study meta-analysis, and a mean sIL-2R difference of 0.555 U/mL between healthy subjects and MDD patients.
- Some markers relate to treatment: elevated baseline TNF was associated with worse antidepressant outcomes; IL-17A was elevated in MDD non-responders; IL-13 showed a 69% reduction at week 52 of SSRI treatment; multi-assay panels including sTNFR2 achieved 69.2% correct classification (62.5% sensitivity, 82.5% specificity) and, in another panel, 91.1% sensitivity and 81.3% specificity for MDD.
- Findings are often contradictory: IL-1β, IL-6, IL-8, IL-10, CCL2, CCL5, and TNF show conflicting elevations or decreases across studies, with unclear relationships between peripheral and CSF levels and between animal and human results.
Methods
- Narrative review of recent data on cytokines as markers of depression, covering their roles in pathogenesis, diagnosis, management, bodily fluid levels, and similarities in animal studies.
- The paper synthesizes human clinical studies, meta-analyses, systematic reviews, and animal models, organized cytokine by cytokine.
- No systematic search strategy, inclusion criteria, or quality assessment is stated in the paper.
Limitations
- The paper states that cytokines are not isolated from the pathophysiologic mechanisms of depression or other psychiatric disorders and that their effects are only part of the whole pathway.
- The paper repeatedly notes inconsistent findings, unclear cause-versus-consequence relationships, and differences between peripheral and central levels or between animal models and human patients.
- Evident from the text: as a narrative review without a described systematic search or quality appraisal, it may be subject to selection and interpretation bias, and many cited studies are small or heterogeneous.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
22 Valid · 0 Not valid · 113 Not checked · 23 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A meta-analysis concluded that IL-1β was significantly elevated in patients with depression and Alzheimer’s disease (AD), while IL-6 was elevated only in patients with depression [38].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
What the sources say
- Partly supportedcites [38] Ng A. Tam W.W. Zhang M.W. Ho C.S. Husain S.F. McIntyre R.S. Ho R.C. IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s Disease: Systematic Review and Meta-Analysis Sci. Rep. 2018 8 12050 10.1038/s41598-018-30487-6 30104698 PMC6089986 sourceExperimental — accuracy not yet measured
The Results (Meta-Analysis for Elderly with and without Alzheimer’s disease) report significantly higher peripheral IL-1β in elderly patients with Alzheimer’s disease than in controls (p = 0.041). The Discussion qualifies this as significant before Bonferroni adjustment, and the Conclusion says that after correction for multiple testing, only IL-6 in elderly patients with depression remained significantly elevated. The citing sentence omits that qualification. (LLM, conf=0.90)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“P2X7 inhibition has been associated with antidepressant-like effects, and IL-1β knockout mice failed to express these receptors [48,49].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
What the sources say
- Not checked yetcites [48] Seil M. Ouaaliti M.E. Abdou Foumekoye S. Pochet S. Dehaye J. Distinct Regulation by Lipopolysaccharides of the Expression of Interleukin-1β by Murine Macrophages and Salivary Glands Innate Immun. 2012 18 14 24 10.1177/1753425910377101 20682589 source
- Could not verifycites [49] Clark A.K. Staniland A.A. Marchand F. Kaan T.K.Y. McMahon S.B. Malcangio M. P2X7-Dependent Release of Interleukin-1 and Nociception in the Spinal Cord Following Lipopolysaccharide J. Neurosci. 2010 30 573 582 10.1523/JNEUROSCI.3295-09.2010 20071520 PMC2880485 sourceExperimental — accuracy not yet measured
The Results section on LPS-induced mechanical hypersensitivity reports that P2X7 antagonists prevented hyperalgesia, not that they had antidepressant-like effects. A search for depression and antidepressant-like behavior found no passage addressing that outcome in our copy; page numbers were unavailable. (LLM, conf=0.75)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Elomaa et al. described elevated IL-5 levels in 58 patients with MDD, though a later meta-analysis did find changes in levels of IL-5 to be inconclusive in depressed patients.”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.5. Interleukin-5
What the sources say
- Supportedcites [35] Köhler C.A. Freitas T.H. Maes M. de Andrade N.Q. Liu C.S. Fernandes B.S. Stubbs B. Solmi M. Veronese N. Herrmann N. Peripheral Cytokine and Chemokine Alterations in Depression: A Meta-Analysis of 82 Studies Acta Psychiatr. Scand. 2017 135 373 387 10.1111/acps.12698 28122130 source
The 'Other mediators' section of our copy lists IL-5 among mediators measured in at least three studies and states that levels 'did not significantly differ between individuals with MDD and HCs'. Table 1 gives the IL-5 primary meta-analysis as 4 studies (198 MDD vs 322 controls), Hedge's g = 0.396 (95% CI -0.072 to 0.865), P = 0.097, I² = 82.1% — a non-significant, borderline estimate with large heterogeneity, i.e. no established IL-5 change in depression. The citing paraphrase renders the paper's null/borderline result as 'inconclusive', which is a fair (if slightly hedged) restatement of what this 2017 meta-analysis reports for IL-5 in MDD patients. (LLM, conf=0.86)
- Not checked yetcites [77] Ho H.-Y. Chin-Hung Chen V. Tzang B.-S. Hsieh C.-C. Wang W.-K. Weng Y.-P. Hsu Y.-T. Hsaio H.-P. Weng J.-C. Chen Y.-L. Circulating Cytokines as Predictors of Depression in Patients with Breast Cancer J. Psychiatr. Res. 2021 136 306 311 10.1016/j.jpsychires.2021.02.037 33636686 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Female rats with lower IL-8 levels are more susceptible to medication and electroconvulsive therapy (ECT) [92,93].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.7. Interleukin-8
What the sources say
- Partly supportedcites [92] Kruse J.L. Vasavada M.M. Olmstead R. Hellemann G. Wade B. Breen E.C. Brooks J.O. Congdon E. Espinoza R. Narr K.L. Depression Treatment Response to Ketamine: Sex-Specific Role of Interleukin-8, but Not Other Inflammatory Markers Transl. Psychiatry 2021 11 167 10.1038/s41398-021-01268-z 33723220 PMC7960960 sourceExperimental — accuracy not yet measured
The Introduction and Discussion report that lower baseline IL-8 was associated with better ECT response in female patients. The Discussion also reports an association with antidepressant-medication response, but says sex differences were not evaluated in those studies. These findings concern people, not female rats. (LLM, conf=0.90)
- Partly supportedcites [93] Kruse J.L. Olmstead R. Hellemann G. Wade B. Jiang J. Vasavada M.M. Brooks Iii J.O. Congdon E. Espinoza R. Narr K.L. Inflammation and Depression Treatment Response to Electroconvulsive Therapy: Sex-Specific Role of Interleukin-8 Brain Behav. Immun. 2020 89 59 66 10.1016/j.bbi.2020.05.069 32479994 PMC7572496 sourceExperimental — accuracy not yet measured
The Discussion reports that lower baseline IL-8 was associated with improvement after ECT in female patients, not female rats. It also reports lower baseline IL-8 among antidepressant-medication responders in a meta-analysis, but says that analysis did not evaluate sex. Thus neither the rat population nor a female-specific medication response is supported. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“IL-4-driven Arg1+ microglia in the hippocampus trigger brain-derived neurotrophic factor (BDNF)-driven neurogenesis in reaction to stress, resulting in improved resilience to stress-induced depression.”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.4. Interleukin-4
What the sources say
- Supportedcites [69] Zhang J. Rong P. Zhang L. He H. Zhou T. Fan Y. Mo L. Zhao Q. Han Y. Li S. IL4-Driven Microglia Modulate Stress Resilience through BDNF-Dependent Neurogenesis Sci. Adv. 2021 7 eabb9888 10.1126/sciadv.abb9888 33731342 PMC7968840 source
The Discussion states that IL4-driven Arg1+ microglia ameliorate chronic stress–induced depressive-like behaviors in mice through BDNF-dependent hippocampal neurogenesis. The Results section on stress-induced depressive-like behaviors also reports that blocking BDNF signaling or neurogenesis abolished the protective effect. (LLM, conf=0.93)
- Not checked yetcites [70] Wachholz S. Knorr A. Mengert L. Plümper J. Sommer R. Juckel G. Friebe A. Interleukin-4 Is a Participant in the Regulation of Depressive-like Behavior Behav. Brain Res. 2017 326 165 172 10.1016/j.bbr.2017.03.020 28315756 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
105 more claims · 13 with their cited sources checked
Create a free account to see all 158 claims and to verify the 151 references still open.
- It may state two separate claims as one. 38
- Probably not a substantial claim. 11
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar associations have been reported with cytokines and neuropeptides in depression (13).”
From Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation (2024) · doi:10.3389/fpsyt.2024.1442954 · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.11. Interleukin-13
“The above-cited meta-analysis by Köhler et al. underpins the association between peripheral IL-13 elevation and MDD [14].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > References
“14. Siwek M. Sowa-Kućma M. Dudek D. Styczeń K. Szewczyk B. Kotarska K. Misztak P. Pilc A. Wolak M. Nowak G. Oxidative Stress Markers in Affective Disorders”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
“The use of intrahippocampal IL-1RA causes downregulation of brain-derived neurotrophic factor (BDNF) in individuals experiencing social isolation [52].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > References
“Brain-Derived Neurotrophic Factor MRNA Downregulation Produced by Social Isolation Is Blocked by Intrahippocampal Interleukin-1 Receptor Antagonist”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.19. Tumor Necrosis Factor
“namely c.-1211T > C—TNF-α (rs1799964)”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.19. Tumor Necrosis Factor
“the C allele in the C/T genotype of rs179964 was associated with positive treatment outcomes and low serum levels of TNF.”
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475 · cited 1×
“Cytokines, hormones, oxidative stress markers, and neuropeptides have been studied in association with depression [8].”
BackgroundSantomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444 · cited 1×
“6%, and while the prevalence is rising globally, the late SARS-CoV-2 pandemic caused problems, especially in middle- and low-income countries [3,4].”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Levels of cytokines have been found significantly altered in depression, and patients, even if otherwise clinically healthy, show elevated or decreased levels of various cytokines and their soluble receptors in bodily fluids [18].”
BackgroundThe regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223 · cited 1×
“This cytokine was first implicated in the etiology of sickness behavior and later linked to depressive disorder along with IL-6 and TNF [36,37].”
BackgroundPeripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
Research works printed but not linked: 10
- Bains N. Abdijadid S. Major Depressive Disorder StatPearls StatPearls Publishing Treasure Island, FL, USA 2022 32644504
- IL3 Interleukin 3 [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3562 (accessed on 18 December 2022)
- IL12A Interleukin 12A [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3592 (accessed on 30 November 2022)
- IL12B Interleukin 12B [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3593 (accessed on 30 November 2022)
- IL13 Interleukin 13 [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3596 (accessed on 30 November 2022)
- IL17A Interleukin 17A [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3605 (accessed on 13 December 2022)
- IL18 Interleukin 18 [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/3606 (accessed on 30 November 2022)
- CCL2 C-C Motif Chemokine Ligand 2 [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/6347 (accessed on 13 December 2022)
- TNF Tumor Necrosis Factor [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/7124 (accessed on 30 November 2022)
- TNFRSF1B TNF Receptor Superfamily Member 1B [Homo Sapiens (Human)]-Gene-NCBI Available online: https://www.ncbi.nlm.nih.gov/gene/7133 (accessed on 30 November 2022)
Cited by
Items 101–200 of 299
Zhang, Y., Wang, D., Liu, J., Sun, J., Liu, X., Fan, B., Lü, C., & Wang, F. (2024) · Nutrients · doi:10.3390/nu16030438 · Cited by 6
“Patients with depression usually experience an increase in systemic inflammation and neuroinflammation, and the inflammatory process is related to the pathophysiology of depression [6,7].”
BackgroundZhang, L.-W., Cui, C., Liu, C., Sun, L.-P., Ouyang, Y.-N., Li, L., Zhang, D.-L., & Yu, H.-L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112330 · Cited by 8
Khalil, M., Kalyoncu, A., & Bellon, A. (2025) · Genes · doi:10.3390/genes16040428 · Cited by 10
“Not surprisingly, numerous studies have demonstrated that pro-inflammatory cytokines are elevated in both depression and sickness behavior [124].”
Bos, M., Monden, R., Wray, N. R., Zhou, Y., Kendler, K. S., Rosmalen, J. G. M., van Loo, H. M., & Snieder, H. (2025) · Psychological Medicine · doi:10.1017/s003329172500100x · Cited by 6
“…IDs, ME/CFS, and FM (Bram, Gottschalk, & Leeds, 2018; Picó-Pérez et al., 2017; Pinto et al., 2023), while inflammation has been associated with FDs and MDD (Andrés-Rodríguez et al., 2020; Burns et al., 2019; Harsanyi, Kupcova, Danisovic, & Klein, 2023; Strawbridge, Sartor, Scott, & Cleare, 2019).”
Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?
Kit, A., Conway, K., Makarowski, S., O'Regan, G., Allen, J., Shultz, S. R., Bodnar, T. S., & Christie, B. R. (2025) · Neurobiology of Stress · doi:10.1016/j.ynstr.2025.100732 · Cited by 6
“Acute inflammation is a rapid, adaptive, protective response initiated by noxious stimuli, by which the immune system sends inflammatory cells to the site of offense (Harsanyi et al., 2023).”
Zhu, F., Wen, Q., Liu, S., Gao, Z., Tao, B., Hu, N., Zhao, Q., Yu, W., Xiao, Y., & Lui, S. (2025) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13895 · Cited by 6
Clock gene influences on sleep quality and HPA axis in major depressive disorder
Ferrer, Á., Pelegrí, A., Labad, J., Sagués, T., Salvat‐Pujol, N., de Arriba‐Arnau, A., Menchón, J. M., Palao, D. J., Costas, J., Carracedo, Á., et al. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.108730 · Cited by 8
Chang, Y., Hsieh, M., Ju, P., & Chang, C. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70927 · Cited by 6
Li, M., Zhang, Q., Wang, Z., Gui, Z., Liu, J., Li, J., Jiang, M., Chang, Z., Han, Q., Yang, B., et al. (2026) · iMeta · doi:10.1002/imt2.70157 · Cited by 12
León-Gómez, B. B., Carmona-Cervelló, M., Dacosta‐Aguayo, R., Lamonja-Vicente, N., Bielsa-Pascual, J., López-Lifante, V. M., Zamora-Putin, V., Molist, G., Montero-Alía, P., Pachón-Camacho, A., et al. (2025) · BJGP Open · doi:10.3399/bjgpo.2024.0098 · Cited by 6
Wei, X., Zhou, T., Wei, X., & Wang, H. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119450 · Cited by 5
Li, C., Li, B., Liu, H., Qu, L., & Wang, H. (2023) · Annals of Translational Medicine · doi:10.21037/atm-23-236 · Cited by 7
“Abnormal TNF expression is linked with various human diseases, including Alzheimer’s disease, cancer, and major depression (40-42).”
Sala-Cîrtog, M., & Sîrbu, I. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021114 · Cited by 5
“In recent years, the role of other molecules like cytokines, neuropeptides, and oxidative stress biomarkers has been linked to depressive disorder [10,11].”
BackgroundLi, B., Ran, K., Jing, Z., Han, W., & Peng, X. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149706 · Cited by 5
Use of Extracellular Monomeric Ubiquitin as a Therapeutic Option for Major Depressive Disorder
Maldonado-García, J. L., García-Mena, L. H., Cabrera, D. M., Pérez‐Sánchez, G., Becerril‐Villanueva, E., Álvarez-Herrera, S., Homberg, T. A., Vallejo‐Castillo, L., Pérez‐Tapia, S. M., Moreno-Lafont, M. C., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17070841 · Cited by 6
Stress, inflammation and coping strategies — association with rheumatological pathology
Teplyakova, O. V., Kuvaeva, I. O., & Volkova, E. V. (2023) · Kazan medical journal · doi:10.17816/kmj568607 · Cited by 7
Guo, Z., Zhong, S.-J., Bai, J.-P., Lang, X.-Y., Cao, M., Hu, Y., Qin, X., & Sun, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-05994-y · Cited by 6
“The recent literature continues to support these observations, indicating the pivotal role of these cytokines in mediating neuroinflammatory processes and depressive symptoms 47 .”
Wu, X., Wu, W., Teng, Y., Yang, D., & Yang, H. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70341 · Cited by 4
RetractedNon-invasive wearable electrochemical biosensors for personalized applications in health management
Kang, X., Luo, A., Khan, N. A., Zhang, T., Ma, X., Zhao, Z., Tang, Y., Wang, W., Dai, K., Liang, A., et al. (2026) · Sensors International · doi:10.1016/j.sintl.2026.100381 · Cited by 5
Deng, T., Chen, H.-S., Wang, H.-J., Shi, Y., Long, L., Jin, Y., Yao, H., Si, T., Yu, X., Li, L., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03551-1 · Cited by 5
Ginsenosides in the management of depression: a comprehensive pharmacological review
Ren, M., Tao, X., Chang, H., Bi, H., Lee, S. M.-Y., & Wan, J. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01416-x · Cited by 5
“Mounting evidence indicates that inflammation is a central driver of depressive pathophysiology and that modulating neuroinflammatory signaling may attenuate disease progression and symptom severity [91– 93].”
Predicting depression risk in COPD patients: a model based on NHANES 2007–2012 data
Zhang, J., & Zhou, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-23342-7 · Cited by 7
“Studies have shown that these biomarkers not only drive the progression of pulmonary disease but may also contribute to the development of depressive symptoms by influencing neuroin-flammatory responses and neurotransmitter metabolism in the central nervous system [22].”
Fu, T., Zhang, W., Zhang, S., & Tian, F. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104927 · Cited by 4
Multi-omics analysis reveals the mechanism of action of Atractylodin against depression
Bao, S., Feng, M., Zhang, X., Xie, M., & Jing, T. (2025) · Journal of Natural Medicines · doi:10.1007/s11418-025-01930-6 · Cited by 4
“The etiology of depression involves the interaction of multiple factors, including genetic susceptibility, environmental stress, and damage to neuroplasticity, and its pathophysiological network remains incompletely understood [8, 9].”
Cheng, Y., Wang, M., Fang, Y., Xu, J., Zheng, J., Ju, P., & Chen, J. (2025) · Brain and Behavior · doi:10.1002/brb3.70796 · Cited by 4
“However, elevated serumlevelsofMIP-1 α wereassociatedwithdepression(Harsanyi et al. 2022).”
Fu, T., Liu, Y., Jia, H., Yao, L., Zhang, S., & Tian, F. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115098 · Cited by 5
Biomarkers associated with treatment outcome in young people with depression: A systematic review
Zierotin, A., Mondelli, V., & Zajkowska, Z. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104082 · Cited by 5
The impact of physical activity on mental disorders
Jakubowska, K., Jerzak, A., Janocha, A., & Ziemba, P. (2024) · Quality in Sport · doi:10.12775/qs.2024.18.53286 · Cited by 9
Using inflammatory biomarkers in early pregnancy to predict subsequent antenatal depression
Zuo, H., Chen, X., Huang, X., Benny, C., Fu, D., Xiu, Q., Cui, X., & Lyu, Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.220 · Cited by 4
Serum L-selectin levels as predictive markers for chronic major depressive disorder progression
Yun, Y., Mun, S., Lee, S., Kang, H., & Lee, J. (2024) · Annals of General Psychiatry · doi:10.1186/s12991-024-00522-0 · Cited by 7
“Recent research on depression biomarkers has revealed numerous associations with biomolecules involved in immune responses, such as inflammation [10].”
Solak, H., Görmüş, Z. I. S., Koca, R. Ö., Güneş, C. E., Iyısoy, M. S., Kurar, E., & Kutlu, S. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01445-1 · Cited by 4
“( Harsanyi et al. 2022 ; Dranovsky and Hen 2006).”
Singh, C., Hempel, F., Endres, K., Engelmann, J., & Tarasov, A. (2025) · 2D Materials · doi:10.1088/2053-1583/adce17 · Cited by 4
Solak, H., Akkuş, M., & Avşar, P. A. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.07.023 · Cited by 4
Lan, Z., Li, J., Zhu, L.-L., Wu, Y., Shen, T., Dai, Y., Su, Y., & Si, T. (2025) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2025.100629 · Cited by 6
“IL-1 IL-1 β has been shown to modulate the expression of brain-derived neurotrophic factor (BDNF), a neurotrophic that plays a pivotal role in neuronal survival and synaptic plasticity (Harsanyi et al., 2022).”
Tang, Q., Li, Y., Yang, T., Fan, X., Li, L., & Hong-sheng, C. (2023) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2023.12.007 · Cited by 7
Pioneering Changes in Psychiatry: Biomarkers, Psychedelics, and AI
Kargbo, R. B. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00333 · Cited by 4
Wang, M., Ma, Y., Zheng, Y., Tao, Y., Mu, W., Yang, L., Li, J., Li, Z., & Shi, C. (2025) · Depression and Anxiety · doi:10.1155/da/3984517 · Cited by 3
“In the pathophysiology of anxiety and depression, research has focused on the roles that cytokines, hormones, oxidative stress markers, and neuropeptides play [66].”
Liu, P., Zhang, Y., Li, J., Du, J., Yang, N., & Dong, Q. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap45975 · Cited by 5
“Inflammatory markers, therefore, hold potential as biomarkers for assessing depressive symptoms, reflecting both the disease state and response to treatment [10].”
D’Aprile, I., Petrillo, G., Begni, V., Creutzberg, K. C., Orso, R., Grassi‐Oliveira, R., Riva, M. A., & Cattaneo, A. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03622-x · Cited by 3
Zhang, Y., Ma, S., & He, Z. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11590-2 · Cited by 4
“Inflammation is hypothesized to play an important role in modulating female HPV infection or depression [38, 39].”
Contreras, V. J., Godoy-González, D., Riquelme-Figueroa, J., Jiménez-Ponce, L., & Carrillo-Monsalve, R. (2025) · Global Health Promotion · doi:10.1177/17579759251372140 · Cited by 3
Winkle-Wagner, R., Goosby, B. J., Kelly, B. T., & Pemberton, B. (2025) · Higher education · doi:10.1007/978-3-031-86738-5_8-1 · Cited by 4
Bubulac, L., Georgescu, T., Zivari, M., Popescu‐Spineni, D., Albu, C.-C., Bobu, A., Nemeth, S., Bogdan-Andreescu, C. F., Gurghean, A. L., & Alecu, A. A. (2025) · Bioengineering · doi:10.3390/bioengineering12111259 · Cited by 6
“Moreover, biomarkers linked to depression, including cytokines, hormones, oxidative stress mediators, and neuropeptides, are gaining attention for their potential relevance in both diagnosis and prevention [40].”
Depression as a Prodromal Symptom of Pancreatic Cancer: A Narrative Review
Deori, C., Andreis, F., Giubileo, V., Noventa, S., Oneda, E., Meriggi, F. A., & Zaniboni, A. (2025) · Cancers · doi:10.3390/cancers18010016 · Cited by 5
“Additional evidence indicates that depression in PDAC patients contributes to a broader picture of psychosocial distress, requiring an integrated clinical approach that also considers preexisting mental health conditions [37].”
Han, X., Liu, Y., Wei, Y., Ma, L., Lim, S. S., & Wang, Z. (2026) · Agricultural Products Processing and Storage · doi:10.1007/s44462-025-00054-0 · Cited by 3
“Consequently, the microbiota-gut-brain (MGB) axis has emerged as a significant focus of research, alongside investigations into biomarkers [8], risk factors [3] and novel therapeutic approaches [9].”
A Possible Role for the Vagus Nerve in Physical and Mental Health
Förster, C. Y., & Shityakov, S. (2026) · Biomolecules · doi:10.3390/biom16010121 · Cited by 4
“He added that physicians frequently prescribe prophylactic antidepressants to cancer patients undergoing treatment that involves cytokines [39,40].”
Li, Z., Qin, P., Sun, Z., Li, L., Liang, P., Zhao, Y., Ren, S., Wang, G., & Yang, J. (2026) · Communications Biology · doi:10.1038/s42003-026-09525-x · Cited by 5
“B.uniformis , B.vulgatus , and B.thetaiotaomicron modulatedthe levels of Th1/Th17-associated cytokines in the hippocampus of depressed mice Cytokines have been reported to play a critical role in depression through the “ gut-brain ” axis 32 .”
Li, Y., Ng, S., Kong, K., Jin, M., Fan, W., Zhou, W., Zhai, Z., & Li, H. (2026) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.101044 · Cited by 7
“Depressive disorders can induce systemic activation of the immune system [11,12], leading to widespread abnormalities in immune mediators and cellular subsets.”
Ahmed, N. A., Hussein, A. A., Khalil, R. G., Yassin, N. Y. S., Abdelaziz, M. A., Geddawy, A., & Ahmed, O. M. (2026) · Biochemistry Research International · doi:10.1155/bri/1761697 · Cited by 3
“In fact, leptin has been shown to contribute to the development of heart failure in rats with experimental myocardial infarction, likely by increasing the proinfammatory cytokine intramyocardial expression [109, 110].”
Yuan, Y., Zhong, X., Zhan, Q., Yin, T., Ku, C., Liu, Y., Yao, Z., Wang, F., Ding, Y., Deng, L., et al. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.07.011 · Cited by 4
Salvia elegans Vahl Counteracting Metabolic Syndrome and Depression in Mice on a High-Fat Diet
Martínez-Hernández, G. B., Jiménez‐Ferrer, E., González‐Cortazar, M., Zamilpa, A., Monterrosas‐Brisson, N., & Herrera-Ruiz, M. L. (2024) · Molecules · doi:10.3390/molecules29174070 · Cited by 5
Milasauskiene, E., Burkauskas, J., Jesmanas, S., Gleiznienė, R., Borutaitė, V., Škėmienė, K., Vaitkienė, P., Adomaitienė, V., Lukoševičius, S., Gradauskienė, B., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311218 · Cited by 3
Wang, J., Xi, R., Wang, Y., Gao, H., Gao, M., Zhang, X., Zhang, L., & Zhang, Y. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae554 · Cited by 5
Ito, N., Miki, R., Kawada, N., Yoshida, M., & Kobayashi, Y. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.072 · Cited by 4
Neuroprotective role of geniposide-loaded UMSC nanovesicles in depression via P2ry12 downregulation
Duan, G., Zou, T., Wu, X., Zhang, Y., Liu, H., & Mei, C. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156581 · Cited by 3
Zeng, L., & Zhang, F. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.186 · Cited by 3
Chaihu-longgu-muli decoction exerts antidepressant effects in rats by regulating the NLRP3 pathway
Liu, A., Zhao, Y., Sun, Y., Halim, J. F., Zhou, D., Yuan, Y., Xu, D., Li, J., & Guo, W.-F. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100617 · Cited by 3
Liu, L., Zhao, X., Zhang, X., Hao, M., Fan, H., Tian, Y., Yang, C., Wang, J., Geng, F., Mo, D., et al. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02002-2 · Cited by 5
Bai, Y., Fang, Z., Dai, H., Zhang, Q., & You, P. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1580151 · Cited by 6
The Role of Long Non-Coding RNA in Anxiety Disorders: A Literature Review
López-Rocha, L. D., Ruíz-Hernández, A., Martínez-Coronilla, G., Leija-Montoya, A. G., Peña-Peña, M., Sánchez‐Muñoz, F., Campoy, U. R., & González-Ramírez, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115042 · Cited by 5
“In a group of women with breast cancer, after breast surgery and before adjuvant therapy, the ones with higher subjective stress showed lower basal and IFN-γ -induced NK cells in addition to reduced T cell proliferative responses to mitogens [75].”
InfluentialCao, X., Wang, H., Hu, Z., Ma, W., Ding, P., Sun, H., & Guo, X. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1511415 · Cited by 3
“IL-6 can act as either anti-in fl ammatory or pro-in fl ammatory cytokines depending on the context (32), its production for a short time after heart injury can help heal and protect the heart.”
Feng, Q., Izzi‐Engbeaya, C. N., Manousou, P., & Woodward, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16562 · Cited by 2
“17 However, findings on the association between SLD and depression remain conflicting.”
Investigating the Role of Autonomic Dysfunction in the Pathogenesis of Depression-Related Dry Eye
Wang, D., Ma, Y., Zhang, M., Li, F. R., Gao, N., Qi, Y., Shang, Z., & Yang, R. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.7.4 · Cited by 3
Peripheral cytokine and monocyte phenotype associations in drug-resistant epilepsy
Tan, T., Sequeira, R. P., Perucca, P., Kwan, P., O'Brien, T. J., & Monif, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-14402-4 · Cited by 5
“For instance, PNES patients often have comorbid psychiatric conditions such as depression, post traumatic stress disorder and anxiety 56,57 , diseases that have been reported to be associated with alterations in circulating cytokine levels 58,59 .”
Design, synthesis, and biological evaluation of THIQ as antidepressive agents
Wei, X., Zhang, M., Guo, Y., Chang, Q., & Qiao, W. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129470 · Cited by 3
Neohesperidin Improves Depressive-Like Behavior Induced by Chronic Unpredictable Mild Stress in Mice
Luo, L., Liu, W., Dong, L., Wang, S., Wang, Q., Jiang, Y., Zhao, M., Liu, A., & Yang, L. (2025) · Neurochemical Research · doi:10.1007/s11064-024-04323-5 · Cited by 4
“Neuroinflam - mation has been strongly linked to depression, and it has been suggested that inflammation may be a cause, not just a consequence, of depressive episodes [30].”
NLRP3 in the dorsal raphe nucleus manipulates the depressive-like behaviors
Cai, J., Zhao, J., Peng, R., Yu, H., He, Y., Zhou, Q., Wang, Y., & Xie, P. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111405 · Cited by 4
“Nod-like receptor (NLR) family pyrin domain containing 3 (NLRP3) is an immune factor in response to cellular stress signals [12] .”
Min, G., Zhang, Y., Zhu, G., Gao, W., Kang, Y., Yu, K., & Yue, J. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06825-8 · Cited by 3
“…group ( n = 50) The observation group ( n = 50) Harsanyi et al. reviewed the relationship between 22 inflammatory cytokines and depression and found sig - nificant changes in the levels of 9 inflammatory cytokines, including IL-1β, IL-2, IL-4, in patients with depression (Harsanyi et al. 2022 ).”
Identifying early screening factors for depression in middle-aged and older adults: A cohort study
Chao, G., Zhang, L., Zhan, Z., & Bao, Y. (2025) · Open Medicine · doi:10.1515/med-2025-1160 · Cited by 2
“As a mental illness, depression a ff ects approximately 5% of the global population, and researchers believe that its underlying mechanisms involve cytokines, hormones, oxidative stress, and neuropeptides [3].”
Ren, L., Wang, H., Su, X., Yang, Y., Zhang, Y., Yin, X., Zhang, D., Hu, G., & Ning, B. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1431182 · Cited by 2
“Clearly, in fl ammatory cytokines may play a critical role in the pathophysiology of depression; thus, targeting in fl ammation through immunomodulation could provide insights for personalized treatment and drug development for depression (27, 28).”
Pereira, L. M. S., Souza, I. D. S. E., Brito, W. R. D. S., dos Santos, E. F., da Costa, F. P., de Sarges, K. M. L., Cantanhede, M. H. D., de Brito, M. T. F. M., da Silva, A. L. S., Leite, M. D. M., et al. (2025) · Human Immunology · doi:10.1016/j.humimm.2025.111341 · Cited by 3
Severe anxiety, depression, and sleep disorders worsen prognosis in patients with septic shock
Li, J.-B., & Rong, W. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i7.107038 · Cited by 2
Hormonal Contraceptives and Depression: A Proteomic Analysis Using Neuronal Models
Thilmany, S., Thomas, A., Reinders, Y., Shakeri, F., Vogel, M., Sickmann, A., Scholl, C., & Thevis, M. (2025) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.70017 · Cited by 2
“Among the enriched GO biological processes (see Figure 5), several terms such as cytokine production, reactive nitrogen species metabolism, and regulation of programmed cell death intersect with pathways previously implicated in the pathophysiology of mood disorders [34–37].”
Veihman, P. R., Kaw, S., Batey, D. S., Schnall, R., & Belloir, J. A. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.09.033 · Cited by 2
Zhou, Y., Yu, J., Qi, L., Tan, H., & Xiao, J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120523 · Cited by 3
Anderson, K. M., Stockman, J. K., Capozzi, E., Meyers‐Pantele, S. A., Karris, M., Mejia, F. C., Meyer, E., Nasr, M. A., & Ghosh, M. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107662 · Cited by 4
Wu, Y., Velu, P., Prabahar, K., Safargar, M., Temuqile, T., & Tian, G. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01968-2 · Cited by 2
“Pro-and anti-inflammatory cytokines, their receptors, and ligands play key roles in the pathophysiology of depression, making inflammation management crucial in treatment [54, 55].”
Huang, S. R., Chen, J. W., Lin, T.-P., Tsai, Y.-T., Kuo, P., Hou, P., & Peng, S. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117090 · Cited by 2
Huang, X., Yan, S., Li, F., Liu, G., Wang, Y., Wu, R., Jin, H., Zhang, X., Li, S., & Xiao, X. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158167 · Cited by 3
Li, K., You, L., Zhen, J., Huang, G., Wang, T., Cai, Y., Zhang, Y., & Xu, A. (2023) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2023.12.001 · Cited by 3
Immune Dysregulation, Inflammation in Characterizing Women with Vulvodynia, Depression, and Both
Zheng, A., Harlow, B. L., & Gereige, J. (2024) · Journal of Women s Health · doi:10.1089/jwh.2023.0422 · Cited by 2
“21,59 This is likely a similar pathway for vulvodynia because there is emerging literature indicating that women who are diagnosed with vulvodynia have an increase in inflammatory markers and cytokines.”
A cross talk on the role of contemporary biomarkers in depression
Vyas, A., & Doshi, G. (2024) · Biomarkers · doi:10.1080/1354750x.2024.2308834 · Cited by 2
“cytokines are a group of small heterogenous peptides that affect inflammation, cell proliferation, and differentiation (Harsanyi et al. 2022).”
BackgroundFurtak, G., Lerch, N., Kozłowski, M., Tkacz, P., Piekara, E., Łagódka, M., Durys, D., Gutowska, I., Widecka, K., Marchelek‐Myśliwiec, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413449 · Cited by 3
“The activation of the inflammatory response and the prolonged dysregulation of several axes disrupts chemokine functions, leading to mental disorders, including anxiety and depression [11].”
InfluentialInflammation as a link between depression and metabolic syndrome
Gorbunova, A. P., Rukavishnikov, G. V., & Mazo, G. E. (2024) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2024-1005 · Cited by 4
Emokpae, M. A., Osifo, J. O., Emokpae, L. A., ERHUNMWUNSE, R. U., & Ayomide, I. B. (2024) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2024.1412020 · Cited by 3
Abukhalaf, D., Koerner, R., Sapna Patel, M. C., Duffy, A., & Prescott, S. M. (2024) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2024.100280 · Cited by 2
“Elevated levels of IL-1 β , IL-6, and CRP are associated with stress and depressive symptoms [24]; [25].”
Bilateral oophorectomy amplifies depression risk following hysterectomy NHANES 2006–2017
Xu, C., Zhao, G., Yao, W., & Zhang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-83675-y · Cited by 3
Janković, M., Spasojević, N., Ferizović, H., Stefanović, B., Virijević, K., & Dronjak, S. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.114893 · Cited by 2
Zhao, D., Ao, X., Yuan, K., Zuo, K., Yang, L., Bian, Z., Xu, H., Cheng, S.-M., Yang, M., Zhao, H., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119792 · Cited by 3
Ayijiang, S., Tiliwaerde, M., Yang, Y., Li, Y., Gao, H., Jia, J., Wang, S., Liu, Q., & Jin, Z. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70033 · Cited by 2
“Concurrent GR suppression likely exacerbates glucocorticoid resistance, creating a pathologic feedback loop that perpetuates HPA axis hyper-activity—a hallmark neuroendocrine disturbance in depression [36, 37].”
What role does salt play in depression and anxiety? A prospective cohort study
Zhu, L., Pan, Y., Xie, J., Pang, C., Gao, L., Li, Y., Zhang, J., Yu, H., Deng, B., & Huang, H. Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119830 · Cited by 2
Su, Z., Chen, Z., Cao, J., Li, C., Duan, J., Zhou, T., Yang, Z., Cheng, Y., Xiao, Z., & Xu, F. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.24.1167 · Cited by 4
Fouad, M. A., Tadros, M. G., & Michel, H. E. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176801 · Cited by 2
Jijón, A. A. B., García, M. A., & Arias, R. T. (2024) · Revista San Gregorio · doi:10.36097/rsan.v1i58.2756 · Cited by 8
Jiang, H., Zhang, J., Li, Q., & Zhou, Y. (2024) · Medicine · doi:10.1097/md.0000000000039726 · Cited by 2
“[39] Another study found that the expression level of TP53 was significantly increased in the plasma transcriptome of MDD patients.”
BackgroundThakurdesai, P. A., Shivsingwale, G. V., & Aswar, U. M. (2024) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3018 · Cited by 1
Scheller, E., Böttcher, E., Schreiber, L. S., Wozniak, D., Schmidt, F. M., & Pelz, J. O. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101009 · Cited by 2
Bertollo, A. G., Soares, S. J. B., Amaral, S. S., de Medeiros, J., Nicolleti, A. O. A., Ibrahim, H. J., Kreuz, K. M., Schuh, L. A., da Silva, B. V., Mingoti, M. E. D., et al. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10576-2 · Cited by 2
Pan, J., Liu, J., Fan, Q., Gao, S., Yu, L., & Zhang, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1606445 · Cited by 1
Correlation between depressive-like behavior and gut microbiota in mice with hypothyroidism
Guo, H.-J., Ma, X., Li, Y., Zhou, Z.-H., Tao, W., Jiang, Y.-H., Li, X., & Zhang, X.-L. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i7.104921 · Cited by 1
Metadata
- Authors
- Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M.
- Affiliations
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia
- Comenius University Bratislava (SK)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-12-29
- Volume
- 24
- Issue
- 1
- Pages
- 578
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9820159
- OpenAlex
- W4313361124
- Semantic Scholar
- ff8ea139489ad0c55b6a066d65875eb9feda6c69
- Cited by
- 299
- References
- 218
- Citations by year
- 2026: 71 · 2025: 117 · 2024: 82 · 2023: 29
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, biomarkers, cytokines, inflammation, major depressive disorder, oxidative stress, neuropeptides, stress response, animal models of depression, depression diagnosis, depression pathogenesis
- MeSH terms
- Animals, Depression, Depressive Disorder, Major, Major Depressive Disorder, Inflammation, Quality of Life, Biomarkers, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
